Peter G.
- Country
- Germany
- Department
- I.Medizinische Klinik und Poliklinik für Gastroenterologie, Hepatologie, Nephrologie
Research Overview
- Safety and Efficacy of PF-08634404 as Monotherapy and in Combination with Ipilimumab in Adults with Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma
- A phase III, multicenter, randomized, open-label trial to evaluate the safety and efficacy of systemic therapy with regorafenib and pembrolizumab, versus locoregional therapy with transarterial chemoembolization (TACE) or transarterial radioembolization (TARE), for the first-line treatment of intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria (REPLACE).
- A PHASE IB/II, OPEN-LABEL, MULTICENTER, RANDOMIZED PLATFORM STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT IMMUNOTHERAPY COMBINATIONS IN PATIENTS WITH SURGICALLY RESECTABLE HEPATOCEULLULAR CARCINOMA (MORPHEUS-NEO HCC)
Data & Insights
Has run more than one trial at 41 of 125 partner sites.
Specializations
Liver Cancer Therapeutics
The investigator specializes in advanced treatment approaches for hepatocellular carcinoma, with particular focus on innovative therapeutic combinations for first-line treatment of liver cancer.
- Advanced HCC Management
- First-line Therapy Development
- Systemic Treatment Approaches
Their research centers on evaluating novel immunotherapy combinations in the treatment of liver malignancies.
Immunotherapy Research
The investigator focuses on studying immunotherapeutic agents and their combinations in oncology, particularly exploring dual checkpoint inhibition strategies.
- Combination Immunotherapy
- Treatment-naive Patients
- Survival Outcomes Research
Their work emphasizes the development of immunotherapy-based treatment protocols for advanced liver cancer.
Comparative Oncology
The investigator conducts research comparing novel therapeutic approaches against established standard of care treatments in hepatic oncology.
- Treatment Comparison Studies
- Clinical Outcomes Analysis
- Therapeutic Strategy Evaluation
Their investigations aim to advance the understanding of treatment efficacy in advanced liver cancer scenarios.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.